Prontosan Wound Gel for Shoulder Joint Replacement Surgery

RO
AG
Overseen ByAllison Gruender, RN, MSN
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.

Who Is on the Research Team?

RO

Randall Otto, MD

Principal Investigator

St. Louis University

Are You a Good Fit for This Trial?

This trial is for individuals undergoing primary shoulder replacement surgery who may be at risk of bacterial infection from Cutibacterium Acnes. Specific eligibility criteria are not provided, but typically participants would need to meet certain health standards and not have conditions that could interfere with the study.

Inclusion Criteria

I am a man over 18 planning a first-time shoulder replacement for specific shoulder conditions.

Exclusion Criteria

Patients with allergy to active ingredients in Prontosan gel
Patient is non-English speaking
I am female.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Surgery and Treatment

Participants undergo shoulder arthroplasty with either Prontosan gel application or no additional dermal preparation

1 day
1 visit (in-person)

Culture Monitoring

Cultures are monitored in the lab for growth of C. acnes

2 weeks

Follow-up

Participants are monitored for safety and effectiveness after surgery

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Prontosan Wound Gel

Trial Overview

The study is testing if applying Prontosan wound gel after making a skin incision during shoulder replacement can reduce the growth of bacteria compared to no additional treatment. It's a comparison between treated versus untreated surgical sites.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Prontosan Wound GelExperimental Treatment1 Intervention
Group II: No skin incision preparationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

St. Louis University

Lead Sponsor

Trials
197
Recruited
41,400+

Innovice, LLC

Collaborator

American Shoulder and Elbow Surgeons

Collaborator

Trials
3
Recruited
220+